Latuda (lurasidone)
- Region
- 🇪🇺 EU
- Active substance
- lurasidone
- Company
- Aziende Chimiche Riunite Angelini Francesco S.p.A.
- Status
- Authorised
- Therapeutic area
- Schizophrenia
- CHMP opinion
- Wed 22 Jan 2014
- EU approval
- Fri 21 Mar 2014
- Application
- EMEA/H/C/002713
- ATC
- N05AE05
- Official record
- www.ema.europa.eu
Indication
Treatment of schizophrenia in adults aged 18 years and over.
Regulatory milestones
No milestones recorded in the last year.
Follow Latuda
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.